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Abstract
Atypical bovine spongiform encephalopathy (BSE) has recently been identified in Europe, North America, and
Japan. It is classified as H-type and L-type BSE according to the molecular mass of the disease-associated prion
protein (PrP
Sc). To investigate the topographical distribution and deposition patterns of immunolabeled PrP
Sc,H -
type BSE isolate was inoculated intracerebrally into cattle. H-type BSE was successfully transmitted to 3 calves, with
incubation periods between 500 and 600 days. Moderate to severe spongiform changes were detected in the
cerebral and cerebellar cortices, basal ganglia, thalamus, and brainstem. H-type BSE was characterized by the
presence of PrP-immunopositive amyloid plaques in the white matter of the cerebrum, basal ganglia, and
thalamus. Moreover, intraglial-type immunolabeled PrP
Sc was prominent throughout the brain. Stellate-type
immunolabeled PrP
Sc was conspicuous in the gray matter of the cerebral cortex, basal ganglia, and thalamus, but
not in the brainstem. In addition, PrP
Sc accumulation was detected in the peripheral nervous tissues, such as
trigeminal ganglia, dorsal root ganglia, optic nerve, retina, and neurohypophysis. Cattle are susceptible to H-type
BSE with a shorter incubation period, showing distinct and distinguishable phenotypes of PrP
Sc accumulation.
Introduction
Bovine spongiform encephalopathy (BSE), which belongs
to a group of diseases called transmissible spongiform
encephalopathies (TSE), is a fatal neurodegenerative dis-
order of cattle. BSE was first identified in the United
K i n g d o mi n1 9 8 6[ 1 ] ,t h e ns p r e a dt oE u r o p e a na sw e l l
as North American countries and Japan, and has
affected more than 190 000 cattle in the world. The
infectious agent responsible for TSE is the disease-asso-
ciated prion protein (PrP
Sc), which is thought to be a
post-translationally modified form of the host-encoded
membrane glycoprotein (PrP
C) [2]. According to the
protein-only hypothesis, PrP
Sc is the principal compo-
nent of the infectious agent.
On the basis of uniform pathology and biochemical
profile of the protease-resistant prion protein (PrP
res)
among BSE-affected cattle, it is assumed that BSE in
cattle is caused by only one prion strain. Since 2003,
variants of BSE (named atypical BSE) have been
detected in Japan, Europe, and North America and clas-
sified in at least two groups, namely, H-type and L-type
BSE, according to the molecular mass of PrP
res,c o m -
pared with those of the classical BSE (named C-type
BSE) [3]. H-type BSE was first identified in France [4],
and L-type BSE, called bovine amyloidotic spongiform
encephalopathy (BASE), was first detected in Italy [5]. It
is accepted that C-type BSE is caused by the consump-
tion of BSE-contaminated feed, whereas the origins of
H-type and L-type BSE remain enigmatic. Hypotheses
for the origin of atypical BSE include (1) infection of
cattle with different BSE agents; (2) infection of cattle
w i t han o n - b o v i n es o u r c eo ru n r e c o g n i z e df o r m so f
infectious TSE agents; (3) genetic mutations in the prion
protein gene; and (4) spontaneous or so-called sporadic
forms of TSE in cattle, limited to old age, like the spora-
dic form of human Creutzfeldt-Jakob disease (CJD)
[6-10]. However, only one genetic mutation has been
f o u n di na nH - t y p eB S Ec a s e[ 1 1 ] .S e q u e n c ea n a l y s i so f
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cases in France [4], Italy [5], and Canada [12]. There-
fore, it seems unrealistic to suggest a genetic origin of
atypical BSE [13]. The transmissibility of atypical H-type
and L-type BSE to mice [13-18] and cattle [19-22] has
been confirmed, and these forms clearly differ from C-
type BSE regarding incubation periods, PrP
res profiles,
protease susceptibility, and spatial distribution patterns
of histopathological lesions and immunolabeled PrP
Sc
[3,6,16,20,22]. Interestingly, C-type [23] and H-type
[14,15] BSE isolates were transmissible to wild-type
mice already in the first passage, whereas L-type BSE
agent failed to transmit in the first passage but was suc-
cessfully transmitted to wild-type mice in the second
passage [17].
Unfortunately, a detailed and all-encompassing analy-
sis of neuropathology and topographical distribution of
immunolabeled PrP
Sc in H-type BSE-affected cattle
could not be performed, since only the obex region is
routinely sampled for BSE surveillance testing and the
remaining brain as well as the carcasses are not available
in most countries [3,10,12,13,24-27]. Recently, clinical
signs and biochemical properties of experimental Ger-
man H-type BSE cases have been reported [20]. The pri-
mary objective of this study was to investigate the
transmissibility of H-type BSE, using a field isolate
detected in the active surveillance program in Canada
[12]. The secondary objective was to extend the knowl-
edge of the topographical distribution and deposition
patterns of immunolabeled PrP
Sc in H-type BSE.
Materials and methods
Animal inoculation
All animal experiments were approved by the Animal
Ethical Committee and the Animal Care and Use Com-
mittee of National Institute of Animal Health. The
Canadian H-type BSE case was of a Charolais cross dis-
playing signs of recumbency prior to euthanasia [12]. By
confirmatory immunohistochemistry, the staining pat-
tern was characterized by a predominant reaction in the
neuropil (including glial cells) and a relatively low level
of intraneuronal, particulate, and stellate immunolabel-
ing in the obex region. The molecular features of PrP
Sc
in cattle were described for the Canadian H-type BSE
[12] and C-type BSE [21]. Brain homogenates were pre-
pared in nine volumes of phosphate-buffered saline
(PBS, pH 7.4), using a multibead shocker (Yasui Kikai
Co., Osaka, Japan). Two female and one neutered 3- to
4-month-old Holstein calves were challenged intracere-
brally with 1 mL of the 10% brain homogenate prepared
from the H-type BSE case. Intracerebral transmission of
C-type BSE has previously been reported in cattle [21].
In brief, the inoculum was injected into the midbrain
via an 18-gauge 7-cm-long disposable needle (NIPRO,
Osaka, Japan), following which the needle was with-
drawn from the brain. Two sham-inoculated Holstein
calves served as controls; they were euthanized at the
age of 27 months.
Tissue processing for histology
The left brain, including the brainstem and cerebellum,
o ft h eH - t y p eB S Ec a s ew a sf i x e di n1 0 %n e u t r a lb u f -
fered formalin (pH 7.4), while the contralateral side was
frozen at -80°C for western blot analysis of PrP
Sc.T i s -
sues of C-type BSE for this study were derived from pre-
viously reported experimental cases [21]. Coronal slices
of the formalin-fixed sample from each animal were cut
serially, treated with 98% formic acid for 60 min at
room temperature (RT) [28], embedded in paraffin wax,
sectioned at 4-μm thickness, stained with hematoxylin &
eosin (HE), and used for immunohistochemistry.
The lesion profile was determined in the HE-stained
sections by scoring the vacuolar changes in 17 different
brain areas as previously described [29]. Selected brain
sections were stained with phenol Congo red [30]. In
brief, Congo red dye dissolved at 0.2 g in 100 mL of dis-
tilled water was mixed with 9 g of NaCl and subse-
quently with an equal volume of 100% ethanol. This
mixture was allowed to stand on ice for 10 min. After
filtration, phenol (Nacalai Tesque, Kyoto, Japan) was
added at 5 g in 100 mL of the supernatant, and the pH
was adjusted to around 3.0 by adding glacial acetic acid.
The sections were stained in this solution for 1 h. After
hematoxylin counterstaining ,t h es e c t i o n sw e r ee x a m -
ined under a polarizing microscope.
PrP
Sc immunolabeling
Dewaxed sections were treated with 3% hydrogen perox-
ide for 10 min, followed by incubation with 10 μg/mL
proteinase K (PK) at RT for 10 min. Thereafter, the sec-
tions were subjected to an antigen retrieval protocol by
alkaline hydrolysis at 60°C for 10 min in 150 mM
sodium hydroxide [31]. They were incubated with 10%
normal goat serum for 10 min and then with the follow-
ing anti-PrP primary antibodies for 60 min: SAF32,
SAF54, SAF84, 12F10, F89/160.1.5, F99/97.6.1, T1 [32],
44B1 [33], and 43C5 [33] as the 9 monoclonal antibo-
dies (mAbs) and B103 [34] and T4 [35] as the 2 rabbit
polyclonal antibodies (pAbs) (Table 1). Working con-
centrations of the mAbs and pAbs were 1 μg/mL and 5
μg/mL, respectively. Immunolabeling was performed
with an anti-mouse or anti-rabbit universal immunoper-
oxidase polymer (Nichirei Histofine Simple Stain MAX
PO (M) or (R); Nichirei, Tokyo, Japan) for 30 min, and
the reaction was visualized using 3,3’-diaminobenzidine
tetrachloride as the chromogen for 7 min. Finally, the
sections were slightly counterstained with Mayer’s
Okada et al. Veterinary Research 2011, 42:79
http://www.veterinaryresearch.org/content/42/1/79
Page 2 of 11hematoxylin. To observe the topographical distribution
of PrP
Sc in the brain with the naked eye, the immunola-
beled sections were photographed and viewed with
Microsoft PowerPoint.
Western blotting
The CNS tissues were homogenized in a buffer contain-
ing 100 mM NaCl and 50 mM Tris-HCl (pH 7.6). The
homogenate was mixed with an equal volume of deter-
gent buffer containing 4% (w/v) Zwittergent 3-14
(Merck, Darmstadt, Germany), 1% (w/v) Sarkosyl, 100
mM NaCl, and 50 mM Tris-HCl (pH 7.6) and incubated
with 0.25-mg collagenase, followed by incubation with
PK (final concentration, 40 μg / m L )a t3 7 ° Cf o r3 0m i n .
PK digestion was terminated using 2 mM Pefabloc. The
sample was then mixed with 2-butanol:methanol (5:1)
and centrifuged at 20000 g for 10 min.
PrP
Sc was extracted from the peripheral nervous,
extranervous, and lymphoid tissues by phosphotungstic
acid precipitation as described previously [36]. The
extracted samples were mixed with a gel-loading buffer
containing 2% (w/v) sodium dodecyl sulfate (SDS) and
boiled for 5 min before electrophoresis. The samples
were then separated by 12% SDS-polyacrylamide gel
electrophoresis (PAGE) and electrically blotted onto a
polyvinylidene fluoride (PVDF) membrane (Millipore,
Billerica, MA, USA). The blotted membrane was incu-
bated with anti-PrP mAbs 6H4 (Prionics, Schlieren,
Switzerland) and SAF84 at RT for 60 min. Signals were
developed with a chemiluminescent substrate (Super-
Signal; Pierce Biotechnology, Rockford, IL, USA). After
PK treatment, some samples were deglycosylated with
N-glycosidase F (PNGase F; New England Biolabs, Bev-
erly, MA, USA), according to the manufacturer’s
instructions.
Polymerase chain reaction (PCR) amplification and DNA
sequencing
In each case, genomic DNA was isolated and purified
from the liver using a GenElute mammalian genomic
DNA purification kit (Sigma, St. Louis, MO, USA)
according to the manufacturer’s instructions. The ORF
(792 bp) of PRNP was amplified using the primers 5’-
ATGGTGAAAAGCCACATAG-3’ and 5’-CTATCC-
TACTATGAGAAAAATG-3’. The purified PCR pro-
ducts of the bovine PRNP were directly sequenced using
ABI 3100-Avant sequencer (Applied Biosystems, Foster
City, CA, USA), with the abovementioned PCR primers.
The nucleotide sequences obtained for the 3 challenged
calves were aligned using the GENETYX software
(GENETYX Co., Tokyo, Japan), with the following Gen-
Bank accession numbers: AY367641, AY367642, and
AY367643.
Results
Clinical signs
The 3 challenged calves developed initial signs of clini-
cal disease approximately 12 months post challenge,
which included disturbance, anxiety, and occasionally
low head carriage. After 3-4 months of the onset of
the clinical disease, the animals showed loss of body
condition. Around 7-10 days prior to euthanasia, the
animals developed ataxia of the forelimbs and hin-
dlimbs and myoclonus and were unable to rise. The
cattle were euthanized at 507 (case 1, code 7749), 574
(case 2, code 9458), and 598 (case 3, code 0728) days
post challenge (mean ± standard deviation, 559.7 ±
47.2 days). The clinical signs were similar in all the 3
H-type BSE-challenged animals. The animals did not
s h o wa n yc h a n g ei nt e m p e r a m e n t ,s u c ha sn e r v o u s n e s s
or aggression.
Table 1 Characteristics of the 11 antibodies and the epitope location of the bovine PrP
Antibodies Epitope Clonality Immunogen Source**
Location Type*
N-terminal region SAF32 62-92 L Monoclonal SAF from infected hamster brain SPI-Bio (Montigny-le-Bretonneux, France)
B103 103-121 L Polyclonal Cattle recPrP FUJIREBIO (Tokyo, Japan) [34]
F89/160.1.5 148-155 L Monoclonal Cattle recPrP VMRD (Pullman, WA, USA)
T1 149-153 L Monoclonal Mouse recPrP Dr Tagawa
12F10 154-163 L Monoclonal Hamster recPrP SPI-Bio
Core region SAF54 168-172 L Monoclonal SAF from infected hamster brain SPI-Bio
44B1 168-242 DC Monoclonal Mouse recPrP Dr Horiuchi [33]
SAF84 175-180 L Monoclonal SAF from infected hamster brain SPI-Bio
43C5 175-181 L Monoclonal Mouse recPrP Dr Horiuchi [33]
C-terminal region T4 221-239 L Polyclonal Cattle recPrP Dr Sata [35]
F99/97.6.1 229-235 L Monoclonal Cattle recPrP VMRD
SAF, scrapie-associated fibrils; recPrP, recombinant prion protein
*L, linear; DC, discontinuous
**manufacturer and reference number
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Scores for the distribution and severity of vacuolation in
the brain were similar among the 3 challenged calves.
Vacuolar changes were generally observed in all the
brain areas. In general, the vacuoles varied in size. The
highest mean lesion scores appeared in the thalamic
nuclei and neuropil of the central gray matter of the
midbrain, and the lowest scores were found in the cau-
dal cerebral and cerebellar cortices. In the vestibular
and pontine nuclei, spongy changes were not as promi-
nent as in the other brainstem nuclei. In the spinal cord
of the animals with clinical disease, mild vacuolation
was present in the neuropil of the gray matter. The
detailed vacuolar lesion profile is shown in Figure 1.
Lesion scores for C-type BSE in cattle have been pre-
viously described [21].
PrP
Sc immunohistochemistry
Initially, immunohistochemistry was performed with the
C-terminus PrP specific antibody F99/97.6.1. Large
amounts of PrP
Sc were deposited diffusely in the cere-
bral cortex, basal ganglia, thalamus, hypothalamus,
brainstem, and spinal cord of all three challenged ani-
mals (Figure 2). The most conspicuous type of PrP
Sc
deposition was fine or coarse particulate-type deposition
in the neuropil of the gray matter throughout the brain
and spinal cord of all the animals (Figures 3a and 3b).
Linear, perineuronal, and intraneuronal types of PrP
Sc
staining, usually detected in C-type BSE-affected cattle,
were observed in the cerebral cortex, basal ganglia, tha-
lamus, and brainstem of the H-type BSE-challenged
cattle (Figure 3). The deposition pattern of PrP
Sc was
characterized by the presence of stellate, intraglial, and
plaque forms in the brain of the H-type BSE-challenged
cattle (Figure 3). Stellate-type PrP
Sc deposition was pre-
dominantly identified in the cerebral cortex, basal gang-
lia, thalamus, hypothalamus, and hippocampus and
often in the cerebellar cortex, but was not visible in the
brainstem and spinal cord (Figure 3e). Intraglial-type
PrP
Sc deposition was very consistent throughout the
white matter of the central nervous system (CNS) and
spinal cord (Figures 3h and 4e-h).
PrP
Sc-positive plaques were scattered throughout the
cerebral white matter (Figure 4). Some PrP
Sc-positive
were also detected in the deep cortical layer of the cere-
brum, internal capsule of the corpus striatum and thala-
mic white matter, and cerebellum (Figures 3f and 4), but
were absent from the brainstem and spinal cord. On the
basis of the morphology of the cores, as revealed after
application of immunohistochemistry, the plaques were
classified into unicentric and multicentric types (Figure
4). Unicentric plaques had a single core and were up to
25 μm in diameter (Figures 4a and 4e). Multicentric pla-
ques were composed of multiple smaller cores clustered
together or a central core surrounded by even smaller
plaques or aggregates, varied in shape and could extend
up to 40 μm in diameter (Figures 4b-4d and 4f-4h). Both
types of plaques were subdivided into two subtypes, that
is, those with a dense compact core and others with a
pale central core. The dense compact core plaques were
less than 20 μm in diameter and smaller than the plaques
with a pale central core; they were uniformly immunola-
b e l e da n dw e r ed i f f i c u l tt od e t e c ti nH Eo rC o n g or e d -
stained sections (Figures 4c and 4g). Furthermore, pla-
ques with a pale central core were generally larger than
that with a dense compact core and stained pale basophi-
lic or amphophilic with HE and positively with Congo
red under polarized light (Figure 4e). The periphery of
these plaques looked like a halo unstained with HE and
Congo red but well immunolabeled with PrP-specific
antibodies. In addition, the granular form of plaque-like
deposits, was rarely detected in the deep cerebral cortex,
basal ganglia, and thalamic nuclei and not detected in the
white matter (Figures 4d and 4h). These deposits were
not stained with Congo red and were composed of aggre-
gates about 5 μm in diameter.
Variability of PrP
Sc immunolabeling with antibodies
The H-type cases were further investigated by immunohis-
tochemistry also using a set of other PrP specific antibo-
dies covering the different regions of PrP (Table 1).
Results of PrP
Sc immunolabeling with each antibody are
summarized in Table 2. The immunolabeling intensity of
each type of PrP
Sc varied with the different primary anti-
bodies. The strongest immunolabeling for both
Figure 1 L e s i o np r o f i l eo fH - t y p eB S E - c h a l l e n g e dc a t t l ei n1 7
brain areas. The different brain areas indicated are as follows: 1,
nucleus of the solitary tract; 2, nucleus of the spinal tract of the
trigeminal nerve; 3, hypoglossal nucleus; 4, vestibular nuclear
complex; 5, cochlear nucleus; 6, cerebellar vermis; 7, central gray
matter; 8, superior colliculus; 9, medial geniculate nucleus; 10,
hypothalamus; 11, dorsomedial nucleus of the thalamus; 12, ventral
intermediate nucleus of the thalamus; 13, frontal cortex; 14, septal
nucleus; 15, caudate nucleus; 16, putamen; 17, claustrum. The lesion
scores for C-type BSE are taken from a previous study [21].
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Sc was evident with mAb
F99/97.6.1 and pAb T4, which recognized the C-terminal
region of PrP, whereas mAb SAF32 and pAb B103, which
recognized the N-terminal region of PrP, showed no or
weak immunolabeling. In general, the core-specific
antibodies used in this study produced varying degrees of
immunolabeling intensity for each extracellular-type PrP
Sc
deposit. Intraneuronal-type PrP
Sc deposits in H-type BSE
showed weaker immunolabeling with the core-specific
antibodies than those in C-type BSE. In addition, the core-
Figure 2 Topographical distribution of PrP
Sc in the CNS of H-type BSE-challenged cattle. An H-type BSE-challenged case (case 1, code
7749) displays prominent immunolabeling in the cerebral and cerebellar cortices, basal ganglia, thalamus, brainstem, and spinal gray matter, but
relatively sparse immunolabeling in the hypothalamus. The 9 different areas indicated are as follows: a, frontal cortex; b, septal nucleus; c,
temporal and parietal cortices and thalamus; d, occipital cortex; e, midbrain; f, pons; g, medulla oblongata at the obex; h, spinal cord; i,
cerebellum. The sections show immunohistochemical labeling with mAb F99/97.6.1 and hematoxylin counterstaining.
Figure 3 PrP
Sc accumulation patterns in the brain of H-type BSE-challenged cattle. Fine particulate-type PrP
Sc accumulation in the neuropil
of the frontal cortex (a). Coarse particulate-type (b), perineuronal-type (c), and linear-type (d) PrP
Sc deposition in the thalamus. Stellate-type
deposition in the caudate nucleus (e, arrows). Plaque-like (f, arrow) and stellate-type (f, arrowhead) deposition in the cerebral cortex.
Intraneuronal-type PrP
Sc accumulation in the olivary nucleus (g). Intraglial-type PrP
Sc deposition in the cerebellar medulla (h). The images show
immunohistochemical labeling with mAb F99/97.6.1 and hematoxylin counterstaining. Scale bars = 20 μm.
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intraglial-type PrP
Sc deposits.
PrP
Sc deposition in additional structures
Positive PrP
Sc immunolabeling was detected in the tri-
geminal and dorsal root ganglia, neurohypophysis,
retina, and optic nerve. In the neurohypophysis, fine
granular PrP
Sc depositions were detected in the unmye-
linated nerve fibers, and intracytoplasmic immunolabel-
ing was detected in the pituicytes. In the retina, intense
granular immunolabeling was observed in the ganglion
cell layer as well as the inner and outer plexiform layers.
In the optic nerve, intraglial immunolabeling was promi-
nent. PrP
Sc was occasionally found in satellite cells and
ganglion cells of the trigeminal and dorsal root ganglia.
No PrP
Sc immunolabeling was detected in the lymphoid
tissues, including the spleen, tonsils, Peyer’s patches,
and lymph nodes, in any of the animals.
Western blot analysis
PrP
res was detected by western blot analysis using mAbs
6H4 and SAF84 in all the animals challenged with H-type
Figure 4 Various types of plaques. Various types of plaques stained with HE (a-d) and immunohistochemical labeling with mAb F99/97.6.1 (e-
h). Unicentric (a and e) and multicentric (b-d and f-h) cores of plaques (arrows) in the white matter of the thalamus (a-c and e-g) and in the
deep cortical area of the frontal lobe (d and h). The inset in the lower left corner of (e) shows an amyloid plaque detected by Congo red
staining in the serial section; it shows birefringence under polarized light. Scale bars = 20 μm.
Table 2 Comparison of immunolabeling intensities of different PrPSc types between C-type and H-type BSE
Extracellular PrP
Sc type Intracellular PrP
Sc type
Antibody Particulate Perinuclear Linear Plaque-like Stellate Intraneuronal Intraglial
C-type H-type C-type H-type C-type H-type C-type H-type C-type H-type C-type H-type C-type H-type
SAF32 + - ± - - - + ± + - ± - ± -
B103 2+ + + ± 2+ ± + + 2+ - + - + -
F89/160.1.5 2+ 2+ 2+ 2+ 2+ 2+ 3+ 3+ 3+ 2+ 2+ + ± -
T1 2+ + 2+ ± 2+ + 2+ 3+ 2+ 2+ 2+ + + -
12F10 3+ 2+ 3+ + 3+ + 3+ 2+ 3+ 2+ 3+ + 2+ -
SAF54 2+ ± 2+ - 2+ - 2+ + 3+ + 2+ + + -
44B1 3+ 2+ 3+ 2+ 3+ 2+ 3+ 3+ 3+ 2+ 3+ 2+ + +
SAF84 3+ 2+ 3+ + 3+ 3+ 3+ 3+ 3+ 3+ 3+ 2+ 2+ -
43C5 3+ 2+ 3+ + 3+ + 3+ 2+ 3+ 2+ 3+ 2+ 2+ +
T4 3+ 2+ 3+ 2+ 3+ 2+ 3+ 3+ 3+ 3+ 3+ 3+ + 3+
F99/97.6.1 3+ 3+ 3+ 3+ 3+ 3+ 3+ 3+ 3+ 3+ 3+ 3+ 2+ 3+
-, none; ±, negligible; +, weak; 2+, distinct; 3+, strong
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for PrP
res. Western blot analysis with 6H4 showed that the
diglycosylated, monoglycosylated, and unglycosylated frag-
ments of PK-treated PrP
res derived from H-type BSE-chal-
lenged cattle were more than those of PrP
res derived from
the C-type BSE-affected cattle. On the contrary, the glyco-
form profiles of PrP
res derived from both the H-type BSE-
and C-type BSE-challenged cattle were similar (Figure 5a
and 5c). With mAb SAF84, a multiple banding pattern
was detected from the H-type BSE sample (Figure 5b).
After deglycosylation with PNGase F treatment, in addi-
tion to ~19 kDa PrP
res fragment, a 10-12 kDa PrP
res frag-
ment was detected from the H-type BSE sample (Figure
5d). This additional 10-12 kDa fragment was not recog-
nized with 6H4. The molecular size and glycoform pat-
terns of PrP
res were similar and conserved in the H-type
BSE-challenged cattle.
In addition to the brain and spinal cord, PrP
res was also
detected in most of the peripheral nerves, ganglia, optic
nerve, retina, hypophysis, and adrenal gland. The intensity
of the signal from most of these tissues was, however, barely
detectable, but the characteristic triple banding was always
detected (Figure 6). No PrP
res signal was detected in the
lymphoid tissues of the three challenged calves. The results
of the western blot analysis are summarized in Table 3.
Analysis of PRNP
The mature PrP sequences (amino acids 25-242) of the
PRNP ORF in the three challenged animals were
compared with the representative bovine PRNP
sequence (GenBank accession number: AJ298878) [37].
The PRNP sequence for case 2 (code 9458) was the
same as the reference sequence, and that for case 1
(code 7749) was also normal with a synonymous poly-
morphism at codon 78 (G or A; no amino acid substitu-
tion). The 2 animals had 6 copies of the octarepeat
region on both the PRNP alleles. The PRNP sequence
for case 3 (code 0728) was also normal, and both alleles
contained five copies of the octarepeat region.
Discussion
This study demonstrated successful intraspecies transmis-
sion of H-type BSE characterized by a shorter incubation
period as compared with C-type BSE [19]. To the best of
our knowledge, thus far, neuropathological and immuno-
histochemical data for H-type BSE have only been
reported from the medulla oblongata at the obex in Ger-
man, United States, and Swedish field cases [10,13,24].
This is related to the fact that only the obex region is
sampled for BSE rapid tests and other brain regions are
often unavailable due to marked autolysis, limitations in
collection infrastructure, or freezing artifacts [10,13,24,25].
This is the first presentation of H-type lesion profiles
involving the whole CNS and additional nervous tissues,
although of experimentally infected animals.
Incubation periods in the cattle challenged with the
Canadian H-type BSE (mean period, 18 months) were
two months longer than those reported in cattle
Figure 5 Western blot analysis. Western blot analysis of PrP
res derived from C-type BSE- and H-type BSE-challenged cattle, with mAbs 6H4 (a
and c) and SAF84 (b and d). Lanes 1 and 8, C-type BSE tissue; lanes 6 and 7, PrP
res-negative bovine brain. Other lanes show banding for H-type
BSE tissue: lane 2, Canadian case; lane 3, case 1 (code 7749); lane 4, case 2 (code 9458); and lane 5, case 3 (code 0728). In panel d, the band
near 14 kDa is of lower molecular mass than 14 kDa. All the samples were digested with 50-μg/mL PK at 37°C for 1 h, and then treated with
PNGase F (c and d). Molecular mass markers (kDa) are shown on the left.
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ence in incubation periods has several potential explana-
tions, which include differences in agents tested,
inoculum titers, and breeding conditions. Infectivity titer
issues might be resolved by comparing second-passage
infection experiment results.
Spongy changes were generally present in the gray
matter throughout the brain and spinal cord, but were
more conspicuous in the cerebral cortices, thalamus,
hypothalamus, and midbrain. In most brain areas,
vacuoles were generally detected in the neuropil and
only occasionally in the neurons. The spatial distribution
pattern of spongiform changes and immunolabeled
PrP
Sc in the brain of an H-type BSE-infected Zebu, ana-
lyzed with N-terminal-specific mAb P4 and C-terminal-
specific mAb F99/97.6.1, was similar to that in C-type
BSE cases [38]. In natural and experimental C-type BSE
cases, spongiform lesions are consistently distributed
throughout the brain, but overall, the lesions in the tha-
lamus and brainstem including the midbrain and
medulla oblongata at the obex are more severe than
those in the cerebral cortices [29,39]. The results of the
present study indicate that the vacuolar lesion score of
t h eH - t y p eB S E - c h a l l e n g e dc attle was higher than that
of C-type BSE-affected cattle [19,29,40,41]. Moreover,
the topographical distribution of PrP
Sc in the brain of
Table 3 Immunohistochemical and western blot analyses
of PrP
Sc in tissue samples obtained from cattle
intracerebrally challenged with H-type BSE
Tissue Case code
7749 9458 0728
IHC WB IHC WB IHC WB
Central nervous system
Cerebral cortex ++++++
Obex ++++++
Cerebrum ++++++
Spinal cord ++++++
Peripheral nervous system
Cauda equina ++++++
Dorsal root ganglia ++++++
Trigeminal ganglia ++++++
Cranial cervical ganglia - + - + - +
Stellate ganglia - + - + - +
Sympathetic trunk - + - + - +
Celiac-mesenteric ganglion complex - + - + - +
Vagus nerve - + - + - +
Facial nerve - + - + - -
Hypoglossal nerve - + - + - -
Phrenic nerve - + - + - +
Accessory nerve - - - + - +
Suprascapular nerve - + - + - +
Brachial plexus - + - + - +
Median nerve - + - + - +
Radial nerve - + - + - +
Sciatic nerve - + - + - +
Tibial nerve - + - + - +
Optic nerve ++++++
Retina ++++++
Pituitary gland ++++++
Adrenal gland - + - + - +
Lymphoid tissues
Spleen ------
Tonsils (palatine, pharyngeal, lingual) ------
Thymus ------
Parotid lymph node ------
Mandibular lymph node ------
Lateral retropharyngeal lymph node ------
Superficial cervical lymph node ------
Brachiocephalic lymph node ------
Axillary lymph node ------
Superficial inguinal lymph node ------
Subiliac lymph node ------
Popliteal lymph node ------
Hepatic lymph node ------
Internal iliac lymph node ------
External iliac lymph node ------
Mesenteric lymph node ------
IHC, immunohistochemistry; WB, western blotting; +, positive for PrP
Sc;- ,
negative for PrP
Sc
Figure 6 Western blot analysis of PrP
res in nervous tissue.
Western blot analysis of PrP
res in the nervous tissue sampled from
the H-type BSE-challenged cattle (case 1, code 7749). 1, cranial
cervical ganglion; 2, vagal nerve (cervical division); 3, vagal nerve
(thoracic division); 4, phrenic nerve; 5, sympathetic trunk (thoracic
division); 6, sympathetic trunk (lumbar division); 7, trigeminal
ganglion; 8, adrenal gland (medulla); 9, facial nerve; 10, hypoglossal
nerve; 11, celiac-mesenteric ganglion complex; 12, cauda equina; 13,
suprascapular nerve. Each lane was loaded with 100 mg of tissue
equivalent. Western blots were probed with mAb 6H4 to detect
PrP
res. Molecular mass standards (kDa) are indicated on the left.
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Page 8 of 11BSE-infected sheep is similar irrespective of the different
c h a l l e n g er o u t e ss u c ha si n t r a cerebral, intravascular, or
intraperitoneal route [42], suggesting common patterns
of neuroinvasion and CNS spread [43]. On the contrary,
the minor differences detected in the distribution of
PrP
Sc in the brain between deer that are orally and
intracerebrally infected with BSE may be due to differ-
ences in the routes of infection [44].
The immunolabeling patterns of PrP
Sc in the cattle
affected with H-type BSE were characterized by the pre-
sence of both PrP
Sc-positive plaques and intraglial- and
stellate-type PrP
Sc accumulations in the brain. Severe
intraneuronal- and intraglial-type PrP
Sc accumulations
as well as plaque-like PrP
Sc aggregates with the absence
of stellate-type PrP
Sc deposition have been reported in
the obex region of H-type BSE-affected animals [10,13].
These immunohistochemical features were detected in
the obex region and coincided with those observed in
the present study. However, neither amyloid plaques nor
stellate-type PrP
Sc depositions have been reported in H-
type BSE-affected cattle, most likely due to their limita-
tion to the medulla oblongata at the obex [8,10,13,24].
Two different types of plaques were found in this
study: unicentric and multicentric PrP plaques. Most of
these plaques were uniformly immunopositive for PrP,
with a dense non-Congophilic core. The plaques that
had a pale central core with a Congophilic reaction
were less frequent. It has been suggested that Congophi-
lic plaques may correspond with the late stage of plaque
formation, whereas non-Congophilic plaques coincide
with the early stage of CJD and Gerstmann-Sträussler-
Scheinker syndrome [45]. The 2 types of PrP
Sc-positive
plaques–unicentric and multicentric–have been
described in L-type BSE [5,19,46]. Our results indicate
that the presence of PrP
Sc plaques in the forebrain but
not in the brainstem is one of the neuropathological fea-
tures in cattle affected with atypical BSE. In addition,
glial-type PrP
Sc deposition in the white matter through-
out the brain seems to be a characteristic feature of H-
type BSE in cattle, as supported by identical findings in
German and Swedish H-type BSE field cases [10,13].
Extracellular PrP
Sc was immunolabeled with N-term-
inal-, core-, and C-terminal-specific antibodies, but
intracellular PrP
Sc did not show immunoreactivity to the
N-terminal-specific anti-PrP antibodies [47,48]. Intracel-
lular PrP
Sc has markedly diminished immunoreactivity
to N-terminal-specific anti-PrP antibodies [47]. How-
ever, N-terminal-specific mAb P4, which recognizes an
epitope at bovine PrP residues 101-107, showed intra-
neuronal PrP
Sc immunolabeling in sheep affected with
C-type BSE [47] and in Zebu affected with H-type BSE
[38]. These results indicate that the epitope region for
either mAb P4 or core-specific anti-PrP antibodies is
located upstream of an intracellular truncation site
[38,48]. The differences in intracellular PrP
Sc truncation
sites between sheep scrapie and ovine BSE [47] as well
as between C-type BSE and H-type BSE [38] most prob-
ably depend on the strain and the tissues and cells [47].
The intensity and patterns of PrP
Sc immunolabeling var-
ied with the different anti-PrP antibodies used, and the
difference in the PrP
Sc immunohistochemical labeling
results might be related to the application of different
technical protocols, especially antigen retrieval methods
[49-51].
The western blot profiles of PrP
res for the H-type BSE-
challenged cattle and the Canadian H-type BSE-infected
brain homogenate used as inoculum were indistinguish-
able. Results of previous studies prove that H-type BSE
isolates have distinct biological and biochemical proper-
ties compared with C-type and L-type BSE isolates
[3,52,53]. The PrP
res in H-type BSE, as detected by mAb
SAF84 recognizing the C-terminus of PrP, was thought
to be composed of 2 fragments with molecular masses
of 19 kDa and 10-12 kDa, possessing a different cleavage
site in the N-terminal region with PK digestion [53].
The higher molecular mass of the unglycosylated PrP
res
molecules, which included an additional 10-12 kDa frag-
ment, in the Canadian H-type BSE case was maintained
in the challenged animals. These unique molecular fea-
tures of PrP in H-type BSE are also well preserved in
transgenic and wild type mice [16,53]. In addition, a dis-
tinct 10-12 kDa fragment detected with C-terminal-spe-
cific antibodies in H-type BSE might be associated with
the presence of PrP plaques [53].
Although PrP
C glycosylation seems to play a critical
role in the maintenance of strain-dependent prion neu-
rotropism [54,55], a recent study has demonstrated that
PrP
Sc glycosylation is not required for the maintenance
of strain-specific neurotropisms [56]. Strain-dependent
prion neurotropism is currently unknown, but several
possibilities have been indicated [56]. Moreover, a local
difference in the PrP
Sc replication rate may be attributed
to a high degree of neurotropism in H-type BSE similar
to that observed in C-type BSE [57].
Since 2003, sporadic and discontinuous occurrence of
atypical BSE has been detected in Europe, North Amer-
ica, and Japan. Although, till date, the origin and fre-
quency of atypical BSE is unknown, a high prevalence is
found in older cattle over the age of eight years. This is
the result of the active surveillance programs using
rapid screening tests, with the exception of a Zebu case
[38]. It has been reported that H-type BSE can be the
result of a naturally occurring, heritable variant caused
by glutamic acid/lysine polymorphism at codon 211 of
the bovine PRNP gene (E211K) [11,58]. However, our
cases, although experimentallyc h a l l e n g e dv i at h ei n t r a -
cranial route, and the original Canadian H-type BSE
field case [11,58] developed the disease without the
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Page 9 of 11novel mutation E211K within PRNP. Therefore, atypical
BSE seemed to be sporadic rather than inherited with a
higher risk in fallen stock than in healthy slaughtered
cattle [8,13,25], suggesting that young adult cattle
affected with atypical BSE might be dormant carriers.
Further studies are required to determine the epidemio-
logical significance and origin of atypical BSE.
The present study demonstrated successful intraspe-
cies transmission of H-type BSE to cattle and the distri-
bution and immunolabeling patterns of PrP
Sc in the
brain of the H-type BSE-challenged cattle. TSE agent
virulence can be minimally defined by oral transmission
of different TSE agents (C-type, L-type, and H-type BSE
agents) [59]. Oral transmission studies with H-type BSE-
infected cattle have been initiated and are underway to
provide information regarding the extent of similarity in
the immunohistochemical and molecular features before
and after transmission. In addition, the present data will
support risk assessments in some peripheral tissues
derived from cattle affected with H-type BSE.
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